Karyopharm stock rating cut to neutral by Rodman on bankruptcy
What it means
- What to watch: $KPTI faces a restructuring risk — the order of who gets paid puts shareholders at the back of the queue.
- How the stock is trading: $KPTI -84.70% in the latest session.
- Timing: It landed during trading hours — the market got to read it live, so the session move beside it may already carry the reaction.
Where the stock stands
$KPTI last changed hands at $0.10, -84.70% on the session, 99% below its 52-week high of $10.99 and 7.1% above its low of $0.09 — within a tenth of its 52-week low. Over the year it has ranged 11517% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $KPTI page.
How much coverage it is getting
In the last 30 days Wook has filed 2 stories about $KPTI — 2 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 0 read bullish, 0 neutral and 2 bearish. This one reads bearish, so it sits squarely with the crowd. 2 of the 2 (100%) came from Investing.com itself, so the count says as much about how often Investing.com hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$KPTI earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
For the receipts, the $KPTI page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $KPTI sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bearish at medium severity because of “cut” and “bankruptcy” in the wording, with nothing on the bullish side to offset them. It was matched to $KPTI. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 2, 2026. $KPTI has moved -8.33% ($0.11 to $0.10). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.